AzTrials
AzTrials

Muscle LossNCT04422665

Preventing Bed-rest Induced Muscle Loss in the Elderly

A study testing Resistance exercise in people with Muscle Loss and Disuse Atrophy, run by University of Birmingham at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Episodes of inactivity due to hospitalisation, as short as 5 days, are associated with rapid muscle and strength loss in the elderly. The observed muscle loss with inactivity is likely due to muscle anabolic resistance and increased breakdown rates of muscle tissue. Read more about this study

Who is it for?
Ages 65 to 80 years, men onlyHealthy volunteers can take part
Conditions the study is for
Muscle Loss, Disuse Atrophy, Protein Metabolism
What is being tested?
Resistance exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited Kingdom
Study dates
1 Sep 2017to 1 Jan 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 80 years
  • Men only
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Males aged between 65-80 years
  • No history of structured resistance training within 10 years prior to study participation.
  • Generally good health as indicated by a thorough health questionnaire.
  • A score of ≥9 points on the Short Physical Performance Battery to assess lower extremity function.
  • Body Mass Index <30kg/m2

Who cannot join

  • Coagulation disorders
  • Myocardial infarction
  • Artery/vein disease
  • Hormone replacement therapy
  • Other chronic/systemic illnesses (i.e. renal failure, chronic obstructive pulmonary disease, cancer).
  • Undergone 2 or more muscle biopsies from each leg previously.
  • Received a stable isotope infusion in the last 3 years prior to study enrollment.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • University of Birmingham, School of Sport, Exercise and Rehabilitation Sciences

    Edgbaston, West Midlands, B15 2TT

Other trials in United Kingdom

About this study

Official title: Exercise 'Prehabilitation': A Novel Intervention to Protect Against Disuse-induced Muscle Atrophy and Sarcopenia in the Old

Episodes of inactivity due to hospitalisation, as short as 5 days, are associated with rapid muscle and strength loss in the elderly. The observed muscle loss with inactivity is likely due to muscle anabolic resistance and increased breakdown rates of muscle tissue. This is of great concern as the average hospital stay in the elderly is 5-6 days. Moreover, minor illnesses not requiring hospitalisation generally require short-term periods of inactive home-based recovery. The accumulation of repeated disuse events in older individuals manifests in a chronic muscle anabolic resistance (i.e. the inability of muscle to respond to anabolic stimuli such as exercise and nutrition) that may underpin the slow but devastating process of age-related muscle loss.

It is our belief that strategies to promote muscle health in ageing and reduce healthcare expenditure, should focus on alleviating muscle deterioration and anabolic resistance during short-term disuse.

In this regard, we propose that resistance exercise (i.e. weight lifting) performed prior to a disuse event (termed 'prehabilitation') may be sufficient to offset muscle loss in older individuals. Thus, we suggest the potent effect of resistance exercise in older muscles may prevent muscle loss during short-term disuse.

Read the detailed description

Participants will be assigned to either single-bout (SINGLE; n=10) or multiple-bouts (MULTI; n=10) of resistance exercise prehabilitation prior to 5 consecutive days of bed rest. Groups will be matched for age, anthropometric characteristics and activity levels. Only males will be studied due to potential gender differences in muscle protein turnover. A single-leg resistance exercise prehabilitation model will allow for a direct within-subject comparison against the non-exercised control leg.

Preliminary Assessments

Following an induction meeting and obtainment of informed consent, participants will report to The National Institute of Health/Wellcome Trust Clinical Research Facility (CRF) at University Hospital Birmingham (UHB) at 0800h having fasted from 2100h the previous night. After measuring height and weight, the following parameters will be determined in the order outlined:

  1. Muscle biopsy, blood and saliva sampling: a muscle biopsy sample will be obtained from a specific thigh muscle under local anaesthetic. A blood sample will then be obtained from a forearm vein. Participants will also provide a saliva sample. This will be obtained prior to the following measurements.
  2. Lower-limb function: The short physical performance battery (SPPB) test will be used.
  3. Body composition: bioelectrical impedance analysis will be used to determine fat/fat-free mass on a whole-body and anatomical regional basis (CRF nurse).
  4. Muscle size/architecture: The thickness of the thigh muscles will be determined via non-invasive ultrasound imaging.
  5. Leg strength and muscle activation: Estimated maximal leg strength will be measured firstly on a standard knee extension exercise machine.
  6. Stable isotope procedure: Immediately following muscle biopsy, blood and saliva sampling, participants will orally consume a small bolus of 'heavy water' tracer to label the body water pool with a small amount of this isotope. Participants will provide a daily saliva sample to monitor body water tracer enrichment. This technique will allow us to quantify muscle protein synthesis over the course of prehabilitation and bed-rest.
  7. Participants will be fitted with an accelerometer and pedometer to asses daily activity levels.
  8. Participants are given a food diary to record daily nutritional intake over a 3-day period.

Exercise Prehabilitation (Days 0-7) Participants will be randomly assigned to undergo 4 resistance exercise bouts the week before (Day 1, 2, 5 and 7), or 1 resistance exercise bout on the evening prior to bed rest (i.e. Day 7). Exercise bouts will consist of 8 sets of single-leg knee extension exercise and 8 sets of single-leg leg curls. The non-exercised control leg will remain passive throughout training. Resistance exercise will be performed at 70% of previously determined maximal strength (10-15 repetitions).

Intervention - 5-days of bed-rest (Days 8-13) Participants will report to the CRF at 0700h the morning immediately after exercise prehabilitation phase. At 0800h, muscle biopsies will be obtained from both legs to assess changes in muscle metabolism over the 7 days of prehabilitation. Participants will then be transported for dual energy x-ray absorptiometry (DXA), Magnetic Resonance Imaging (MRI) and ultrasound assessment of body/muscle composition, after which the 5 consecutive days of strict bed rest will begin. The bed rest model will mimic a traditional inpatient hospital stay and reflect the level of muscle unloading that occurs in older individuals following acute illness. Participants will spend the majority of time in bed and will be allowed to adjust the hospital bed head height for reading, eating and watching television, but will otherwise be instructed to lie flat in bed. Bathing/hygiene will be performed in a wheelchair at a sink. The bathroom accessed using a wheelchair. Adherence to bed rest will be monitored by nursing staff and through daily analysis of accelerometry data.

Post Intervention Assessments (Day 13) On the morning after completion of the 5-day bed rest phase (i.e. Day 13) participants will awake at 0700h in the CRF and remain in bed for assessment of muscle protein synthesis in trained and untrained control legs. A cannula will be inserted into a vein of both forearms for frequent blood sampling and a stable isotope tracer infusion. During the tracer infusion, muscle biopsies will be obtained from both trained and untrained legs before and after consumption of a milk protein drink, to assess muscle metabolism. Participants will then be transported by wheelchair for repeat bioelectrical impedance analysis, MRI and ultrasound scans to assess body/muscle composition. Leg strength will be reassessed in trained and untrained legs. A physiotherapist will perform a functional assessment of participants before they are discharged.

Rehabilitation Training Participants will be given the opportunity to complete a 6-week rehabilitation programme, consisting of a progressive 3 x weekly leg resistance training with protein supplementation, designed to fully restore any loss in muscle mass and strength from short-term bed rest. Resistance training rehabilitation will not form a specific study objective, but muscle size and strength will be assessed to ensure restoration of any muscle decline from bed rest.

Being tested
Resistance exercise
Medical subject headings
Muscular Atrophy, Muscular Disorders, Atrophic, Sarcopenia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Resistance exerciseOther

    Single-legged resistance exercise

Study groups in NCT04422665
Study groupRoleWhat they receive
Single ExerciseExperimentalSubjects allocated to this group will perform a single bout of one-legged resistance exercise. This bout will take place 1 day prior to the start of the bed rest. The resistance exercise will consist of 8 sets of leg extensions and 8 sets of leg curls. The non-exercising leg will serve as an internal control. The dominant leg will perform the exercise.
Receives: Other: Resistance exercise
Multi ExerciseExperimentalSubjects allocated to this group will perform 4 bouts of one-legged resistance exercise. These bouts will take place on alternate days the week leading up to the bed rest. Each resistance exercise bout will consist of 8 sets of leg extensions and 8 sets of leg curls. The non-exercising leg will serve as an internal control. The dominant leg will perform the exercise.
Receives: Other: Resistance exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Integrated myofibrillar protein synthesis rates

    Myofibrillar protein synthesis rates will be measured during the prehabilitation and bed rest period in both the exercising and resting leg.

    Measured: 2 years

  2. Muscle mass via MRI

    Muscle volume in the quadriceps will be assessed before and after bed rest using magnetic resonance imaging techniques

    Measured: 2 years

Secondary outcomes (13)
  1. Muscle fibre properties

    Via immunohistochemical staining procedures muscle fibre cross sectional area will be determined

    Measured: 2 years

  2. Physical activity levels

    Daily average time spent in sedentary, light, moderate or vigorous intensity activity using an accelerometer

    Measured: 2 years

  3. Step-count

    activity will be determined using accelerometry. Furthermore, step count will be Daily step-count assessed using a hip-worn pedometer

    Measured: 2 years

  4. Plasma biomarkers of metabolic health

    Blood markers - serum total cholesterol, serum high-density lipoprotein cholesterol, serum non-high-density lipoprotein cholesterol, total cholesterol, serum non-esterified fatty acids, serum triglycerides (units of measure for all - mmol/L)

    Measured: 2 years

  5. Serum insulin

    Via ELISA kits, resting insulin will be assessed using baseline plasma samples from before and after the bed rest period (pmol/l)

    Measured: 2 years

  6. Intramuscular signaling via western blot

    Western blots for phosphorylation of key anabolic and catabolic signaling proteins will be performed.

    Measured: 2 years

  7. Gene expression

    Search Results Web results

    Reverse transcription polymerase chain reaction (RT-PCR) will be performed to assess gene-expression of muscle anabolic and catabolic genes.

    Measured: 2 years

  8. Dietary intake

    Dietary intake will be assessed using 3-day weighed food diaries.

    Measured: 2 years

  9. Body composition

    Bioelectrical impedance analysis will be used to determine whole body fat and fat-free mass (units are % of total body mass for both fat and fat-free mass).

    Measured: 2 years

  10. Leg strength

    Estimated maximal leg strength will be determined for the leg extension and leg curl before and after the bed rest period

    Measured: 2 years

  11. Height

    measured using a stadiometer (cm)

    Measured: 2 years

  12. Body weight

    Measured using a digital weighing scale (kg)

    Measured: 2 years

  13. Body Mass Index

    Weight and height will be combined to report BMI in kg/m^2

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jun 2020
  2. Study start1 Sep 2017
  3. Primary completion1 Oct 2019
  4. Study completion1 Jan 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly allocated to one of two intervention groups. Due to the single-legged typed of resistance exercise, each subject will be its own control.
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04422665
Sponsor's protocol ID
RG_16-100
Status last verified
Jan 2020
First submitted
1 Jun 2020
Last updated
9 Jun 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Smeuninx B, Elhassan YS, Sapey E, Rushton AB, Morgan PT, Korzepa M, Belfield AE, Philp A, Brook MS, Gharahdaghi N, Wilkinson D, Smith K, Atherton PJ, Breen L. A single bout of prior resistance exercise attenuates muscle atrophy and declines in myofibrillar protein synthesis during bed-rest in older men. J Physiol. 2025 Jan;603(1):87-105. doi: 10.1113/JP285130. Epub 2023 Oct 19.

    PubMed 37856286

Questions about this trial

What is this clinical trial studying?

A study testing Resistance exercise in people with Muscle Loss and Disuse Atrophy, run by University of Birmingham at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Integrated myofibrillar protein synthesis rates (time frame: 2 years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04422665, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in